BRIEF published on 06/18/2026 at 08:50, 2 months 8 days ago EUROPLASMA: 2025 Annual Report available Decarbonization Funding Europlasma Annual Report Pollution Control
BRIEF published on 06/11/2026 at 20:35, 2 months 14 days ago EUROPLASMA: 2025 Annual Results EBITDA Revenue Funding EUROPLASMA 2025 Uncertain
BRIEF published on 06/09/2026 at 18:05, 2 months 17 days ago Europlasma issues 600 bonds for €3 million Convertible Bonds Shareholder Dilution Funding Stock Price Europlasma
BRIEF published on 06/05/2026 at 10:27, 2 months 21 days ago EUROPLASMA: Statement of voting rights and shares as of May 31, 2026 Voting Rights Europlasma Environment Defense Shares In Circulation
BRIEF published on 05/27/2026 at 18:05, 2 months 30 days ago Europlasma extends negotiations to sell its defense activities Funding Europlasma Negotiations Euronext Market Defense Transfer
BRIEF published on 05/12/2026 at 09:33, 3 months 14 days ago EUROPLASMA: Summary of the total number of voting rights and shares Share Capital Voting Rights Actions Europlasma April 30, 2026
BRIEF published on 05/12/2026 at 09:32, 3 months 14 days ago EUROPLASMA: Details on share capital as of April 30, 2026 Share Capital Voting Rights Europlasma Financial Transparency Environment
BRIEF published on 04/30/2026 at 17:50, 3 months 26 days ago Europlasma: New bond financing and postponement of 2025 accounts Actions Funding Europlasma Dilution OCABSA
BRIEF published on 04/24/2026 at 18:35, 4 months 2 days ago EUROPLASMA raises €2 million through convertible bonds Convertible Bonds Funding Europlasma Growth Capital Dilution
BRIEF published on 04/24/2026 at 18:35, 4 months 2 days ago Europlasma borrows 2 million euros for growth Convertible Bonds Funding Europlasma Growth Dilution
Published on 08/26/2026 at 17:40, 1 hour 6 minutes ago Camino Closes $5.8 Million Brokered Private Placement of Units and Concurrent $9.4 Million Non-Brokered Private Placement of Convertible Debentures
Published on 08/26/2026 at 15:25, 3 hours 21 minutes ago CF Energy Announces Financial Results for the Three-Month and Six-Month Periods Ended June 30, 2026
Published on 08/26/2026 at 15:00, 3 hours 46 minutes ago Commercial Launch Initiated for Neonorm Dog, Jaguar Health's Non-Prescription Product for Support of Normal Stool Consistency and GI Fluid Balance in Dogs
Published on 08/26/2026 at 15:00, 3 hours 46 minutes ago Arcus Announces Voting Results of the Annual General and Special Meeting
Published on 08/26/2026 at 14:30, 4 hours 16 minutes ago Klondike Gold Reports Additional Montana Creek Royalty Gold Receipts, Announces Phase 2 2026 Drill Program and Provides Exploration Update
Published on 08/26/2026 at 18:30, 16 minutes ago Heidelberg Pharma AG and Huadong Medicine Receive NMPA Approval for Clinical Trial of HDP-101 Combination Therapy in China
Published on 08/26/2026 at 18:00, 46 minutes ago MHM Corporate: reduces the nominal value of its shares to €0.011
Published on 08/26/2026 at 17:45, 1 hour 1 minute ago LIGHTON: Information concerning the total number of voting rights and shares in the share capital as of 31 July 2026.
Published on 08/26/2026 at 17:15, 1 hour 31 minutes ago PANASONIC TOUGHBOOK CELEBRATES 30 YEARS OF FRONTLINE INNOVATION FOR MOBILE TEAMS
Published on 08/26/2026 at 16:55, 1 hour 51 minutes ago Piramal Pharma Strengthens Future Ready Operations with 22.6% Emissions Reduction, 41% Renewable Energy and Zero USFDA OAI Observations
Published on 08/26/2026 at 18:02, 44 minutes ago Altareit: Altarea press release regarding the Primonial matter
Published on 08/26/2026 at 18:00, 46 minutes ago Altarea: Comprehensive settlement agreement reached, ending the dispute between Altarea and the shareholders of the Praemia group (formerly Primonial group)
Published on 08/25/2026 at 17:45, 1 day 1 hour ago CEGEDIM: DISCLOSURE OF SHARE CAPITAL AND VOTING RIGHTS
Published on 08/25/2026 at 17:45, 1 day 1 hour ago Imerys-08-2026-information-share-capital-and-voting-rights-as-of-31-July-2026
